Tanium Appoints Dan Streetman as Chief Executive Officer
Tanium, a leading IT operations and security management company and the premier supplier of converged endpoint management (XEM), today announced the appointment of Dan Streetman to the role of chief executive officer. Orion Hindawi, who is the co-founder and current CEO of Tanium, will assume the role of executive chairman. In this new role, Orion will continue to drive the strategic vision and technical innovation at Tanium as well as continue his engagement with Tanium’s strategic partners and customers. David Hindawi, co-founder of Tanium, will transition to chairman emeritus.
In his new role, Streetman will continue to strengthen Tanium’s commitment to protecting enterprises, organizations, and their people, while fortifying and evolving the company’s customer-facing operations, partner strategy, product strategy, and development.
Streetman will build on the strong market momentum that Tanium has seen, including coming off a record fiscal year in terms of revenue and new customer growth, impactful new product introductions, and the rapid adoption of Tanium’s converged endpoint management platform.
Streetman brings extensive and seasoned experience to Tanium. Most recently, he served as CEO of Allvue Systems; prior to that, he served as CEO of TIBCO Software Inc. In his earlier career, Streetman oversaw significant data-driven transformations at BMC, Salesforce, and C3.ai.
“Tanium is a mission-driven company whose commitment to serving customers’ needs is second to none,” said Streetman. “As digital transformation continues to create complexity and upend the cybersecurity landscape, organizations need a comprehensive endpoint management platform that protects their organizations and their people while helping them to break the point-product-proliferation cycle that has unfortunately left customers even less secure. It is an enormous opportunity to lead Tanium and am deeply committed to furthering its mission to provide certainty in uncertain times.”
“Founding and leading Tanium as its chief executive officer has been an honor, both personally and professionally,” said Orion Hindawi. “What started as an idea to help secure companies in the face of growing digital dependence and cyberattacks has blossomed into an endpoint management industry leader. Dan is a leader who shares our values, and I am proud that he is coming aboard to help write the next chapter of Tanium’s story. I have full confidence in his vision and his ability to responsibly nurture our organization’s growth.”
Today, with its converged endpoint management platform (XEM), Tanium is the premier vendor delivering real-time visibility, control, and remediation, all within a single platform. In addition, Tanium is expanding its platform capabilities to enable businesses to improve end-user productivity and provide a superior digital employee work experience. By bringing digital experience management capabilities into XEM, Tanium is poised to be an early leader in this new emerging market.
Streetman becomes the newest addition to an executive leadership team that possesses a wealth of experience, including Bina Chaurasia, chief administrative and operating officer; Charles Ross, chief customer officer; Marc Levine, chief financial officer; Nic Surpatanu, chief product officer; Steve Daheb, chief marketing officer; Tobias Julén, chief people officer; and Tyker Fagg, chief revenue officer.
About Tanium
Tanium, the industry’s only provider of converged endpoint management (XEM), leads the paradigm shift in legacy approaches to managing complex security and technology environments. Only Tanium unifies teams and workflows and protects every endpoint from cyber threats by integrating IT, Compliance, Security, and Risk into a single platform that delivers comprehensive visibility across devices, a unified set of controls, and a common taxonomy for a single shared purpose: to protect critical information and infrastructure at scale. Tanium has been named to the Forbes Cloud 100 list for seven consecutive years and ranks on Fortune’s list of the Best Large Workplaces in Technology. In fact, more than half of the Fortune 100 and the U.S. armed forces trust Tanium to protect people; defend data; secure systems; and see and control every endpoint, team, and workflow everywhere. That’s the power of certainty. Visit www.tanium.com and follow us on LinkedIn and Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230201005890/en/
Contact information
KC Higgins
Tanium PR
kc.higgins@tanium.com
+ 1 303.434.8163
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik13.1.2026 16:01:00 EET | Press release
Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025. Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh. The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “R&D organ
Wasabi Raises $70M in New Equity to Power the Next Era of Data Infrastructure13.1.2026 16:00:00 EET | Press release
Wasabi Technologies, the Hot Cloud Storage company, today announced a $70 million equity funding round led by L2 Point Management with participation from Pure Storage and existing investors including Fidelity Management & Research Company. The new round values Wasabi at $1.8 billion and brings the company’s total funding to over $600 million. The capital will be used to accelerate Wasabi’s expansion into AI infrastructure, broaden its global footprint, and enhance its product portfolio to meet the growing data demands of enterprises and AI developers worldwide. “We’re ushering in the next generation of cloud storage, powering data-intensive workloads like generative AI and autonomous systems,” said David Friend, co-founder and CEO of Wasabi Technologies. “This funding underscores Wasabi’s strong market position and continued growth as enterprises and AI developers alike seek a better, more predictable alternative to the hyperscalers.” Wasabi disrupted the cloud storage model in 2017 wi
Armis Secures Italy’s Primary Public Healthcare Provider for the City of Naples as Cyber Threats Increase13.1.2026 15:00:00 EET | Press release
Armis, the cyber exposure management & security company, today announced that ASL Napoli 1 Centro, Italy’s primary public healthcare provider for the City of Naples, is securing its attack surface using Armis Centrix™, the Armis Cyber Exposure Management Platform. Prior to working with Armis, ASL Napoli 1 Centro did not have the tools or capabilities to monitor physical and virtual assets in real time, which posed a challenge for its security and compliance. Armis Centrix™ was deployed with a clear goal: to provide ASL Napoli 1 Centro with a comprehensive, real-time view of its connected biomedical inventory and the associated risks to the overall environment. “Time-to-value was practically immediate; Armis began delivering valuable information as soon as the system was activated and connected to our internal network,” said Fulvio Paone, Director of the ICT and Digital Transformation Unit at ASL Napoli 1 Centro. “Armis has given us visibility into a critical area. This isn’t just about
Opengear Introduces CM8000 and OM1300: Two New Paths to Network Resilience as Outages Surge13.1.2026 15:00:00 EET | Press release
Opengear, a Digi International company (NASDAQ, DGII), today announced two new additions to its Network Resilience Platform: the CM8000 Series and the OM1300 Series. These next generation devices deliver compact, flexible, and automation-ready out-of-band infrastructure designed for a time when outages are increasing and distributed sites continue to scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113807672/en/ Opengear Introduces CM8000 and OM1300: Two New Paths to Network Resilience as Outages Surge According to Opengear research, 84 percent of CIOs and CISOs have experienced a rise in outages over the past two years. The CM8000 Series and OM1300 Series were purpose-built to ensure that IT teams maintain access and control even when the production network is unavailable. The two series provide complementary approaches: CM8000 Series A serial-first recovery platform with integrated power control for core branches,
GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug13.1.2026 15:00:00 EET | Press release
The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue the development of Debio1453, a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae. With 82 million new cases each year, and the continued spread of multidrug-resistant N. gonorrhoeae strains, gonorrhea represents a global health crisis. This new partnership will help ensure that gonorrhea continues to be a treatable disease and will alleviate the risk of the emergence of future resistance, by ensuring that the antibiotic pipeline continues to be replenished. Gonorrhea caused by N. gonorrhoeae is currently in danger of becoming untreatable because of antimicrobial resistance (AMR). Having developed resistance to almost all antibiotics used to treat it, only one last recommended treatment, ceftriaxone, remains effective, and now we are seeing a growing number of cases that are
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom